Dr. Annette de Kloet Research Support

R01HL145028 (de Kloet, PI) 1/15/2019-11/30/2023
Interrogating distinct angiotensin type-1 and type-2 receptor containing brain circuits to understand and
alleviate hypertension
Agency: NIH/NHLBI
Priority Score: 24 (15 Percentile)
R01HL136595 (Krause/Sumners, PI; de Kloet, Co-I) 12/1/2017-11/30/2021
Neurons expressing angiotensin type 2 receptors in the NTS as an access point for cardiovascular control.
Agency: NIH/NHLBI
Priority Score: 34 (15 Percentile)
R35HL150750-01 (Krause, PI; de Kloet, Co-I) 2/01/2020-1/31/2027
Targeting brain angiotensin signaling to discern and alleviate stress-related disease
Agency: NIH/NHLBI
Role: Co-investigator (20% effort)
Priority Score: 24 (no percentile given)
Completed Research Support:
17GRNT33660969 (de Kloet, PI) 7/1/2017-6/30/2019
‘Targeting Angiotensin-Vasopressin Interactions in the Brain to Alleviate Hypertension’
Agency: American Heart Association (AHA)/ Great Rivers Affiliate
Type: Grant-in-aid
1R00 HL125805 (de Kloet, PI) 12/1/2014-8/31/2019
‘Novel Role of Central AT2R in Blood Pressure Regulation”
Agency: NIH/NHLBI
Priority Score: 16 (No Percentile Given)
R01HL139868 (Krause, PI; de Kloet, Co-I) 12/1/2017-11/30/2021
Targeting brain angiotensin signaling to discern and alleviate stress-related disease
Agency: NIH/NHLBI
Priority Score: 28 (12 Percentile)